The American Medical Association (AMA) announced that the Current Procedural Terminology (CPT) code set has been updated by the CPT Editorial Panel to include vaccine and administration codes that are unique to the COVID-19 vaccine candidate under development by Novavax.
The AMA said the provisional CPT codes will be effective for use on the condition that the Novavax COVID-19 vaccine receives approval or emergency use authorization from the U.S. Food and Drug Administration (FDA). The AMA also said it was releasing the codes early to allow time for developers to update electronic health-record systems.
“Accurately correlating vaccinated patients with one of the available COVID-19 vaccines is critical for managing immunizations. This challenge is managed with unique CPT codes that clinically distinguish each COVID-19 vaccine and provide the needed informational precision to ensure optimal vaccine distribution and administration,” said AMA President Susan R. Bailey, MD.
The Novavax COVID-19 vaccine has been assigned the Category I CPT code of 91304.In addition to the new vaccine-specific product CPT code, the Novavax COVID-19 vaccine has been issued two specific codes for administering the two-dose vaccine: code of 0041A for the first dose and 0042A for the second dose.
